Australia markets close in 2 hours 24 minutes

Prestige BioPharma Limited (950210.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
8,100.00+10.00 (+0.12%)
At close: 03:30PM KST
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Assets
Current assets
Cash
Cash and cash equivalents
125,021,951
268,650,508
458,975,123
45,976,240
Other short-term investments
176,390,480
34,619,069
377,683
2,422,781
Total cash
301,412,431
303,269,577
459,352,806
48,399,021
Net receivables
132,721
-
-
-
Inventory
7,146,027
2,156,949
-
-
Other current assets
-
6,139,104
584,078
-
Total current assets
311,475,621
311,565,630
459,936,884
49,811,379
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
343,656,696
46,321,212
10,131,469
6,680,461
Accumulated depreciation
-33,218,529
-7,979,030
-3,694,007
-2,161,745
Net property, plant and equipment
310,438,169
38,342,182
6,437,462
4,518,716
Goodwill
10,191,578
-
-
-
Intangible assets
108,719,695
65,312,308
109,022,985
95,010,695
Other long-term assets
-
9,883,041
4,610,550
1,421,628
Total non-current assets
430,124,583
188,247,599
144,229,537
110,286,707
Total assets
741,600,204
499,813,229
604,166,420
160,098,087
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
31,175,508
0
2,873,025
0
Accounts payable
462,148
2,623,877
-
-
Other current liabilities
1,543,852
3,452,173
-
-
Total current liabilities
134,888,052
41,794,133
14,046,479
8,476,816
Non-current liabilities
Long-term debt
50,190,138
-
-
61,256
Deferred tax liabilities
7,368,339
-
-
-
Deferred revenues
1,592,722
25,427,363
11,587,909
11,387,215
Other long-term liabilities
1
1
1
-
Total non-current liabilities
60,477,356
28,083,240
15,159,287
13,821,811
Total liabilities
195,365,408
69,877,373
29,205,765
22,298,627
Stockholders' equity
Common stock
690,174,731
679,712,759
594,071,790
152,779,419
Retained earnings
-246,151,329
-259,601,048
-27,954,242
-21,890,737
Total stockholders' equity
450,510,553
429,935,856
574,960,655
137,799,459
Total liabilities and stockholders' equity
741,600,204
499,813,229
604,166,420
160,098,087